Saxagliptin, a new DPP-4 inhibitor for the treatment of type 2 diabetes mellitus: novel aspects

被引：0
作者：
Pedrianes Martin, P. [1 ]
de Pablos Velasco, P. L. [1 ]
机构：
[1] Hosp Univ Dr Negrin, Dept Endocrinol & Nutr, Las Palmas Gran Canaria, Spain
来源：
AVANCES EN DIABETOLOGIA | 2010年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：446 / 448
页数：3
相关论文
共 13 条
  • [1] Agencia Europea del Medicamento, ONGL EPAR INF
  • [2] Boulton DW, 2009, CLIN PHARMACOL THER, V85, pS96
  • [3] Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial
    Chacra, A. R.
    Tan, G. H.
    Apanovitch, A.
    Ravichandran, S.
    List, J.
    Chen, R.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (09) : 1395 - 1406
  • [4] The Efficacy and Safety of Saxagliptin When Added to Metformin Therapy in Patients With Inadequately Controlled Type 2 Diabetes With Metformin Alone
    DeFronzo, Ralph A.
    Hissa, Miguel N.
    Garber, Alan J.
    Gross, Jorge Luiz
    Duan, Raina Yuyan
    Ravichandran, Shoba
    Chen, Roland S.
    [J]. DIABETES CARE, 2009, 32 (09) : 1649 - 1655
  • [5] Glucagon-like peptides: Regulators of cell proliferation, differentiation, and apoptosis
    Drucker, DJ
    [J]. MOLECULAR ENDOCRINOLOGY, 2003, 17 (02) : 161 - 171
  • [6] PLASMA INSULIN RESPONSE TO ORAL + INTRAVENOUS GLUCOSE ADMINISTRATION
    ELRICK, H
    HLAD, CJ
    ARAI, Y
    STIMMLER, L
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1964, 24 (10) : 1076 - +
  • [7] A Systematic Assessment of Cardiovascular Outcomes in the Saxagliptin Drug Development Program for Type 2 Diabetes
    Frederich, Robert
    Alexander, John H.
    Fiedorek, Fred T.
    Donovan, Mark
    Berglind, Niklas
    Harris, Susan
    Chen, Roland
    Wolf, Robert
    Mahaffey, Kenneth W.
    [J]. POSTGRADUATE MEDICINE, 2010, 122 (03) : 16 - 27
  • [8] Saxagliptin Added to a Thiazolidinedione Improves Glycemic Control in Patients with Type 2 Diabetes and Inadequate Control on Thiazolidinedione Alone
    Hollander, Priscilla
    Li, Jia
    Allen, Elsie
    Chen, Roland
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (12) : 4810 - 4819
  • [9] International Diabetes Federation, 2006, THE DIAB ATL
  • [10] Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial
    Jadzinsky, M.
    Pfuetzner, A.
    Paz-Pacheco, E.
    Xu, Z.
    Allen, E.
    Chen, R.
    [J]. DIABETES OBESITY & METABOLISM, 2009, 11 (06) : 611 - 622
12